Weed (BUDZ) Depreciation & Amortization (CF) (2010 - 2026)
Weed's (BUDZ) quarterly Depreciation & Amortization (CF) came in at $5622.0 in Q1 2026, little changed year-on-year from $5622.0 in Q1 2025, and little changed quarter-over-quarter from $5622.0 in Q1 2025.
Weed (BUDZ) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Weed's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $5622.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $5622.0 in Q1 2026; TTM through Mar 2026 was $5622.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $22487.0, changed 0.44% from the prior year.
- Depreciation & Amortization (CF) held at $5622.0 in Q1 2026 per BUDZ's latest filing, from $5622.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $34949.0 in Q1 2022 and bottomed at $3711.0 in Q4 2023.
- The 5-year median for Depreciation & Amortization (CF) is $20143.0 (2023), against an average of $16060.3.
- Across the five-year window, Depreciation & Amortization (CF) gained 4.77% in 2022 and plunged 83.98% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $23163.0 in 2022, then plunged by 83.98% to $3711.0 in 2023, then soared by 54.16% to $5721.0 in 2024, then declined by 1.73% to $5622.0 in 2025, then changed by 0.0% to $5622.0 in 2026.
- Per Business Quant, the three latest BUDZ Depreciation & Amortization (CF) figures stand at $5622.0 (Q1 2026), $5622.0 (Q1 2025), and $5721.0 (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | 5,622.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,622.00 |
| Mar 31, 2026 | 5,622.00 |
| Mar 31, 2025 | 5,622.00 |
| Mar 31, 2025 | 5,622.00 |
| Mar 31, 2024 | 5,721.00 |
| Mar 31, 2024 | 5,721.00 |
| Dec 31, 2023 | 3,711.00 |
| Dec 31, 2023 | 3,711.00 |
| Sep 30, 2023 | 5,120.00 |
| Sep 30, 2023 | 5,120.00 |
| Jun 30, 2023 | 20,143.00 |
| Jun 30, 2023 | 20,143.00 |
| Mar 31, 2023 | 24,030.00 |
| Mar 31, 2023 | 24,030.00 |
| Dec 31, 2022 | 23,163.00 |
| Dec 31, 2022 | 23,163.00 |
| Sep 30, 2022 | 20,605.00 |
| Sep 30, 2022 | 20,605.00 |
| Jun 30, 2022 | 27,977.00 |
| Jun 30, 2022 | 27,977.00 |